Industry News

Industry News

In cancer immunotherapy obesity can be a liability

Nov 05, 2014

Packing on the pounds may lead to dangerous inflammation in response to anti-cancer treatment, according to a study by William Murphy and colleages at UC Davis. Read More

Novel time-reversal technology improves imaging of cancerous tissues

Nov 05, 2014

As a child, it was fascinating to put a flashlight up to our palms to see the light shine through the hand. Washington University in St. Read More

Physics, statistics and genetics come together to reveal cancer's strategies

Nov 05, 2014

Nate Silver and Richard Feynman walk into a bar and bump into a biologist . . . Read More

Impact of meditation, support groups seen at cellular level in breast cancer survivors

Nov 05, 2014

For the first time, researchers have shown that practising mindfulness meditation or being involved in a support group has a positive physical impact at the cellular level in breast cancer survivors. Read More

Can Tai Chi reduce inflammation for breast cancer survivors?

Nov 05, 2014

Tai Chi has been linked with numerous health benefits. Now, a UCLA study claims that the Chinese martial art reduces inflammation among breast cancer survivors with insomnia. Read More

Combination treatment for metastatic melanoma results in longer overall survival

Nov 04, 2014

Among patients with metastatic melanoma, treatment with a combination of the drugs sargramostim plus ipilimumab, compared with ipilimumab alone, resulted in longer overall survival and lower... Read More

NSAIDs induce 'suicide' in potentially cancerous intestinal cells

Nov 04, 2014

A new study finally explains the mechanism behind the protective effects of NSAIDs against colorectal cancer. The drugs cause cells carrying a gene mutation to initiate suicide. Read More

Positive Phase II preliminary results of Validive for the prevention of severe oral mucositis in head and neck cancer patients

Nov 04, 2014

Onxeo S.A., an innovative biopharmaceutical company specializing in the development of orphan oncology drugs, has announced positive preliminary top-line results from its Phase II clinical trial of... Read More

Vanderbilt-led study investigates potential postpartum breast cancer therapy

Nov 04, 2014

Nearly 25 percent of all breast cancers among premenopausal women occur within two to five years following a pregnancy. Read More

First detailed picture of a cancer-related cell enzyme in action on a chromosome unit

Nov 04, 2014

A landmark study published in the journal Nature provides new insight into the function of an enzyme related to the BRCA1 breast cancer protein. Read More

Previous Page   Next Page